Skip to main content
Premium Trial:

Request an Annual Quote

Joel Campbell, Ian Lyons

Premium
Definiens has named Joel Campbell as vice president and general manager for its US operations and David Fullerton as vice president of worldwide professional services.
 
Campbell joins the firm from the Environmental Systems Research Institute, where he was director of US sales. Fullerton was in charge of professional services at Documentum and also held several marketing and services roles with Hewlett-Packard.
 

 
Stem Cell Innovations has named Ian Lyons as chief scientific officer. Lyons was previously research area manager and principal scientist for Invitrogen, where his responsibilities included developing the company's portfolio of products for human stem cell research. Prior to joining Invitrogen, Lyons held a variety of senior positions at BresaGen.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.